United Kingdom

MYOS RENS Technology Inc (MYOS.OQ)

MYOS.OQ on NASDAQ Stock Exchange Capital Market

16 Mar 2018
Change (% chg)

$-0.04 (-3.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle... (more)
No analyst recommendations are available for .


Beta: 0.64
Market Cap(Mil.): $7.99
Shares Outstanding(Mil.): 6.34
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 21.07 13.52
EPS (TTM): -- -- --
ROI: -- 11.93 35.27
ROE: -- 15.17 16.93

BRIEF-Myos Rens Technology CEO Issues Shareholder Letter

* MYOS RENS TECHNOLOGY CEO ISSUES SHAREHOLDER LETTER Source text for Eikon: Further company coverage:

11 Jan 2018

BRIEF-MYOS RENS Technology reports qtrly loss per share $‍0.13​

* MYOS RENS Technology Inc reports third quarter 2017 financial results

14 Nov 2017

BRIEF-Myos Rens Technology files for mixed shelf of up to $75 mln

* Files for mixed shelf of up to $75 million - sec filing Source text: (http://bit.ly/2z7GifH) Further company coverage:

25 Oct 2017

BRIEF-Myos Rens Technology Inc appoints Joseph Mannello as permanent CEO

* Myos Rens Technology Inc appoints Joseph Mannello as permanent chief executive officer

20 Sep 2017


Earnings vs. Estimates

No consensus analysis data available.